Form 4: Amgen SVP Derek Miller Reports Stock Disposal to Cover Tax Obligations

Derek Miller, SVP of Human Resources at Amgen, disposed of 71 shares of common stock on April 30, 2024, to satisfy tax withholding obligations related to vested restricted stock units.

Summary

• On April 30, 2024, Derek Miller, SVP of Human Resources at Amgen, disposed of 71 shares of Amgen common stock.
• The transaction was executed at a price of $276.38 per share.
• This disposal was to cover tax obligations related to vested Restricted Stock Units (RSUs).
• Following the transaction, Miller beneficially owns 8,348 shares of Amgen common stock, including RSUs and Dividend Equivalents (DEs).

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to an executive's stock transaction for tax purposes. It doesn't convey any particularly positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions. This transaction is typical for executives receiving equity compensation.

Comparison to Industry Standards

• Executive compensation packages often include stock options and restricted stock units (RSUs) as a way to align management's interests with those of shareholders.
• The vesting schedules and terms of Amgen's equity incentive plan appear consistent with industry norms for large, publicly traded companies.
• Companies like Johnson & Johnson, Pfizer, and Merck also utilize similar equity compensation strategies for their executives.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it is a routine stock disposal by an executive for tax purposes.

Key Dates